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OPEN

Altered dynamics of visual contextual interactions
in Parkinson’s disease
M. Isabel Vanegas
Simon P. Kelly1,8

1,2

, Annabelle Blangero1,3, James E. Galvin4, Alessandro Di Rocco5, Angelo Quartarone6, M. Felice Ghilardi7 and

Over the last decades, psychophysical and electrophysiological studies in patients and animal models of Parkinson’s disease (PD),
have consistently revealed a number of visual abnormalities. In particular, speciﬁc alterations of contrast sensitivity curves,
electroretinogram (ERG), and visual-evoked potentials (VEP), have been attributed to dopaminergic retinal depletion. However,
fundamental mechanisms of cortical visual processing, such as normalization or “gain control” computations, have not yet been
examined in PD patients. Here, we measured electrophysiological indices of gain control in both space (surround suppression) and
time (sensory adaptation) in PD patients based on steady-state VEP (ssVEP). Compared with controls, patients exhibited a
signiﬁcantly higher initial ssVEP amplitude that quickly decayed over time, and greater relative suppression of ssVEP amplitude as a
function of surrounding stimulus contrast. Meanwhile, EEG frequency spectra were broadly elevated in patients relative to controls.
Thus, contrary to what might be expected given the reduced contrast sensitivity often reported in PD, visual neural responses are
not weaker; rather, they are initially larger but undergo an exaggerated degree of spatial and temporal gain control and are
embedded within a greater background noise level. These differences may reﬂect cortical mechanisms that compensate for
dysfunctional center-surround interactions at the retinal level.
npj Parkinson’s Disease (2019)5:13 ; https://doi.org/10.1038/s41531-019-0085-5

INTRODUCTION
Parkinson’s disease (PD) is a progressive neurological disorder
characterized by dopamine deﬁciency most famously in striatal
circuits of the basal ganglia, but also in other dopamine-regulated
systems, including the retina.1–3 The involvement of circuits other
than the basal ganglia could explain some of the non-motor
symptoms including sleep regulation problems, autonomic
dysfunction, hyposmia, and visual abnormalities.4
Visual symptoms in PD range from blurry vision, decreased
ability to discern color, loss of contrast sensitivity to circadian
dysregulation, and visual hallucinations.5–7 Systematic abnormalities have also been reported by electrophysiological and
psychophysical studies. Pattern electroretinogram (PERG)
responses in patients and animal models are decreased in
amplitude and increased in latency compared with controls,8–12
particularly in an intermediate range of spatial frequencies (2–5
cycles per degree; cpd) where contrast sensitivity is highest.9,11
Pattern visual-evoked potential (PVEP) studies have shown parallel
effects,13–15 including delayed latency of the N70 and P100
component in a similar range of spatial frequencies and for
temporal frequencies between 4 and 5 Hz,16 and phase delay of a
low-frequency steady-state response.17 Acute levodopa administration in general reversed both PERG and PVEP abnormalities,
suggesting that dopamine has an important role in visual
processing.11–15,17 Psychophysical studies of spatiotemporal tuning curves in PD patients have conﬁrmed a major loss of contrast

sensitivity for spatial frequencies in the 2–4 cpd range and
temporal frequencies between 4 and 8 Hz.18–20 Given the overlap
in the affected spatial and temporal frequency ranges, it is
plausible that these perceptual abnormalities are linked to the
retinal dysfunction reﬂected in the PERG, and both may arise from
the dopaminergic cell degeneration that has been observed in the
retina in PD.2,21–23 Dopaminergic amacrine cells are present in the
retinal interplexiform layer and are key players in neural
transmission from photoreceptors to ganglion cells and in the
generation of center-surround interactions of ganglion cell’s
receptive ﬁelds, thus contributing to spatial frequency tuning.23–
25
Further, mouse models of retinal dopamine deﬁciency have
shown loss of contrast sensitivity and visual acuity, resembling the
visual abnormalities described in PD.26
Although those ﬁndings provide an extensive characterization
of the retinally mediated visual abnormalities present in PD,
relatively little is known regarding potential differences in visual
processing at the early cortical level, and, to our knowledge, there
has yet been no systematic study of fundamental aspects of visual
processing such as spatial and temporal gain control. Here we
addressed this gap by examining cortically generated, steadystate visual-evoked potentials (ssVEP) in PD and their modulation
by surrounding spatial context and temporal adaptation.
We employed a recently developed paradigm designed to
probe visual surround suppression whereby the perceived
intensity of a stimulus decreases under the presence of a

1
Department of Biomedical Engineering, The City College of The City University of New York, New York, NY, USA; 2Department of Ophthalmology and Visual Sciences, University
of Utah, Salt Lake City, UT, USA; 3OCTO Technology, Paris, France; 4Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA; 5Parkinson’s and
Movement Disorders, Northwell Health, New York, NY, USA; 6IRCCS Centro Neurolesi Bonino Pulejo, Department of Biomedical, Dental Science and Morphological and Functional
Images, University of Messina, Messina, Italy; 7Department of Physiology, Pharmacology & Neuroscience, CUNY School of Medicine, New York, NY, USA and 8School of Electrical
and Electronic Engineering, University College Dublin, Belﬁeld, Dublin 4, Dublin, Ireland
Correspondence: M. Isabel Vanegas (isabel.vanegas@hsc.utah.edu) or M. Felice Ghilardi (lice.mg79@gmail.com) or Simon P. Kelly (simon.kelly@ucd.ie)

Received: 19 February 2019 Accepted: 29 May 2019

Published in partnership with the Parkinson’s Foundation

M.I. Vanegas et al.

surrounding pattern,27,28 a phenomenon that relies on lateral,
feedback, and feedforward connections from the earliest stages of
information processing in the retina to visual cortex.29,30 As the
focus of our investigation was on cortical processing, we used
spatial and temporal frequencies lying outside the ranges that
typically reveal retinal abnormalities in PD. We reasoned that, if
the only alterations in cortex are those inherited from the retina,
one should expect little or no difference in cortical responses.
We found several differences in patients with PD compared
with healthy controls: (1) a greater background noise level in the
frequency spectrum; (2) a higher visual response (ssVEP amplitude) that quickly adapts over time, and (3) a stronger relative
suppression of the ssVEP amplitude under the presence of
surrounding stimuli. These overall signatures of visual contextual
interactions indicate that contrast gain control is abnormal in PD
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Fig. 1 Background frequency spectrum proﬁles in patients versus
controls. Fast Fourier transforms were computed on the last 2240 ms
of all trials with 0% foreground and 0% surround contrast (blank
screen, shown in inset) and then averaged across trials and across
subjects within each group. Patients showed signiﬁcantly higher
spectral amplitudes, marked with asterisks for each of the
corresponding frequency bins (bootstrapping test, p < 0.05). Shaded
error bars indicate mean ± standard error of the mean (s.e.m.)
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and thus may serve as biomarkers to aid diagnosis and to evaluate
therapeutic efﬁcacy.
RESULTS
Overview
Data were analyzed from a short surround-suppression paradigm
recorded as part of a larger study of 28 PD patients and 30 healthy
age-matched controls. In this paradigm, subjects passively viewed a
series of 2.4-s long trials in which four “foreground” grating stimuli
ﬂickered on-and-off at 25 Hz, embedded within a static (nonﬂickering) surround grating pattern, with both the foreground (FG)
and surround (SS) contrasts varying randomly from trial to trial.
Background (no-stimulus) frequency spectrum proﬁles
As differences in background spectral EEG amplitude have
previously been reported in PD31–34 and would impact the
estimation of ssVEP amplitudes driven by the external ﬂicker
stimulation, it was important ﬁrst to characterize such background
spectral differences. EEG spectra computed from trials with zero
foreground contrast and zero surround contrast (blank screen),
averaged across a cluster of six parieto-occipital electrodes where
ssVEPs were measured, revealed a broadly elevated spectrum in
PD relative to controls (Fig. 1). A bootstrap statistical test at the
critical frequency of 25 Hz revealed a signiﬁcant difference in the
means (p < 0.05). Importantly, the spectral difference extended
through the θ [4–7 Hz], α [8–12 Hz], and β [18–35 Hz] bands.
The broad spectral elevation seen under no stimulation
conditions would also have the effect of elevating the amplitude
of the 25-Hz ssVEP under the ﬂicker-stimulus conditions when
measured in the same way, even if there were no underlying
differences in the amplitude of the exogenous response to the
ﬂicker. To eliminate this potential confound we took two
measures. First, rather than averaging the single-trial spectra, we
computed Fourier spectra on the average across trials per
condition, thus averaging-out the background activity levels while
retaining the ssVEP signal because it is strictly phase-locked to the
stimulus (Fig. 2a). Second, we further used the blank-screen
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Fig. 2 Background noise as a function of number of trials for both subject groups. a Frequency spectrum for PD and Ctrl, computed using one
to the maximum amount of trials in the blank-screen (baseline) condition of 0% foreground and 0% surround contrast. b Amplitude at the
25 Hz bin as a function of number of trials. A fast Fourier transform (FFT) was computed on the average time-domain signals across the given
number of trials ﬁrst, with that number selected randomly 1000 times from the total trials available for that condition, and the resulting FFTs
averaged. Background noise levels matched when the FFT was computed on the average signal across the maximum available trials (up to
eight per subject) for PD subjects and half of the total (up to four trials per subject) for control subjects
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Fig. 3 Contrast response functions for three different surround contrast conditions. a Patients with Parkinson’s disease (PD). b Control
subjects. A fast Fourier transform (FFT) was computed for a 2240-ms window beginning 160 ms after stimulus onset to extract the single
amplitude value at the frequency of stimulation 25 Hz. Contrast response functions are constructed from the ssVEP amplitude in each stimulus
conﬁguration of foreground (FG) and surround (SS) contrasts. Foreground stimulus varied across ﬁve levels of contrast: 0, 25, 50, 75, and 100%.
Surround stimulus varied across three levels of contrast: 0% contrast (black trace), 50% contrast (brown trace), and 100% contrast (yellow
trace). Insets show stimulus conﬁgurations for FG 100% embedded in SS of 0 and 50% contrast. c Surround-suppression ratio. Each point
corresponds to a subject. The suppression ratio is computed as the ratio between the ssVEP amplitude for FG = 100%, SS = 100% and the
ssVEP amplitude for FG = 100%, SS = 0%. Error bars indicate s.e.m. d Topographical distribution of the 25 Hz steady-state visual-evoked
potential amplitude as a grand average between patients and control subjects, for trials with 75 or 100% contrast foreground embedded in a
midgray surround (0% contrast). The cluster of electrodes chosen to measure and statistically test ssVEP amplitude are marked with star
symbols

condition to determine a lower number of trials to average within
each control subject such that the background noise was elevated
to the same average level as the PD patients. Tracing background
noise levels in the 25 Hz frequency bin during the no-ﬂickerstimulus condition revealed that equal levels of background noise
were achieved in both groups when the maximum number of
available trials per condition was included for the PD group and
about half of the total trials (3–4) for the controls (Fig. 2b). This
random trial rejection policy was then applied in the same way in
the ﬂicker conditions.

Surround-suppression effects
Applying this noise-equalization approach, we examined ssVEP
contrast response functions and temporal proﬁles (Figs. 3 and 4).
These analyses were carried out on subsets of age-matched
patients and controls without cognitive impairment (eleven per
group, see methods). Contrast response functions show that ssVEP
amplitude increased as a function of foreground contrast in both
groups, and decreased as the contrast of the surround stimulus
increased (Fig. 3a, b).
As in our study of younger healthy subjects,27 we computed a
summary metric of the surround-suppression effect as the ratio
between ssVEP amplitude corresponding to FG = 100%, SS =
100% and the ssVEP amplitude for FG = 100%, SS = 0% (Fig. 3c).
Suppression ratios were 0.46 ± 0.04 for PD and 0.71 ± 0.10 (mean
± s.e.m) for control subjects, revealing a signiﬁcantly stronger
surround-suppression effect in PD subjects (t20 = −2.3304, p =
0.0304). Thus, ssVEP amplitude showed a greater relative
reduction in patients with PD than in controls under the presence
of surrounding stimuli of increasing contrasts. We found no group
difference in terms of contrast response function range (t20 = 0.8;
p = 0.43), computed as the difference between the ssVEP
amplitude at maximum ﬂicker contrast embedded in a midgray
surround (FG = 100%, SS = 0%), and the ssVEP amplitude without
either ﬂicker or surround (FG = 0%, SS = 0%).

Published in partnership with the Parkinson’s Foundation

Temporal response proﬁles
Temporal proﬁles of the visual response were constructed by
plotting ssVEP amplitude over the duration of visual stimulation
(short-time Fourier transform) for each stimulus condition. We
found a steep increase of the visual response in the ﬁrst 500 ms
after ﬂicker onset, followed by a decay that reﬂected temporal
adaptation. This was more evident for the high foreground
contrasts. (Fig. 4a, b). The results of an analysis of variance
(ANOVA) shown in Table 1 (see Methods) revealed signiﬁcant
differences across groups that depended on contrast levels
and time.
To unpack this, we conducted a bootstrapping analysis testing
for group differences at each timepoint and for each contrast
combination. We found signiﬁcant differences only for time points
between 420 and 840 ms in the 75% FG, 0% SS condition, and for
timepoints between 140 and 1400 ms in the 100% FG, 0% SS
condition (see asterisks, Fig. 4). As the amplitude increase in PD
appeared to be restricted to earlier timepoints for the unsurrounded, high contrast stimuli, we compared with post hoc test
the rates of temporal decline. A Wilcoxon rank-sum test on the
slope of a line ﬁt overall timepoints from 500 to 1000 ms after
stimulus onset indicated a signiﬁcantly steeper, faster decay of the
visual response in PD subjects (Z = −2.37; p = 0.0179).
We next examined whether these differences could be
described with a model with divisive normalization reﬂecting
surround suppression and exponential decay functions to capture
temporally adapting foreground and surround drives (see
Methods). Shufﬂe statistics applied to the group-average data ﬁts
indicated a signiﬁcant difference in suppression factor (β = 1.31 in
PD and 0.338 in Controls), consistent with the above ﬁndings
based on the suppression ratio. However, the difference in no
other model parameters reached signiﬁcance, including the time
constant of temporal decay (τ) and the maximum amplitude Rm, as
may have been expected from the results above.
Finally, we determined whether such visual abnormalities were
related to characteristics of PD. We found no signiﬁcant
correlations between UPDRS motor scores and maximum ssVEP
amplitude (ssVEP amplitude for FG = 100%, SS = 0% in the
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Fig. 4 Temporal analysis. a Patients with PD. b Control subjects. The group-average ssVEP amplitude was tracked over the duration of the
visual stimulation, with stimulus onset at 0 ms. We computed a short-time Fourier transform (STFT) on sliding windows of 560 ms with an
overlap of 75% over the 2.4-s trial length, starting from 280 ms prior to stimulus onset. Temporal response proﬁles for increasing FG contrasts
are plotted from left to right (0, 25, 50, 75, 100%) and each of the three surround contrasts are superimposed in each plot (black for 0%, brown
for 50%, yellow for 100% contrast). The colored lines in cyan, purple, and magenta represent the model ﬁt to the data, in which FG and
divisive surround drives each exponentially decay (i.e., adapt) to varying degrees. Shaded error bars indicate mean ± s.e.m. Asterisks indicate
timepoints with signiﬁcantly higher amplitude of the visual response (ssVEP) in patients, reached for foreground stimulus of 75 and 100%
contrast with surround contrast of 0% (p < 0.05 in bootstrapping analysis)

Table 1.

Factorial ANOVA showing the main effects and interactions
between group, time, foreground, and surround contrasts
F statistic

p value

Group × time × foreground ×
surround contrast

F8,13 = 2.706

p = 0.008

Group

F1,20 = 3.738

p = 0.0674

Foreground

F4,17 = 16.496 p = 6.7911 × 10–10

Foreground × group

F4,17 = 0.606

p = 0.659

Surround contrast

F2,19 = 1.660

p = 0.203

Surround contrast × group

F2,19 = 4.033

p = 0.025

Time
Time × group

F1,20 = 21.595 p = 0.000155
F1,20 = 5.881 p = 0.025

Foreground × surround contrast

F8,13 = 7.942

p = 5.5932 × 10−9

Foreground × surround contrast ×
group

F8,13 = 1.438

p = 0.185

Foreground × time

F4,17 = 31.424 p = 1.0006 × 10−15

Foreground × time × group

F4,17 = 4.783

Surround contrast × time

F2,19 = 10.439 p = 0.000225

p = 0.002

Surround contrast × time × group

F2,19 = 1.851

p = 0.170

Foreground × surround contrast ×
time

F8,13 = 9.421

p = 1.2695 × 10−10

contrast response function), or suppression ratio (Pearson r =
−0.11; p = 0.759 and r = 0.32, p = 0.37, respectively). Similarly,
disease duration was not signiﬁcantly correlated with maximum
ssVEP amplitude and suppression ratio (r = 0.32; p = 0.364, and
r = 0.53, p = 0.116, respectively). Moreover, therapy did not
signiﬁcantly inﬂuence VEP measurements: in fact, the levels of
levodopa equivalent dose did not correlate either with maximum
npj Parkinson’s Disease (2019) 13

ssVEP amplitude (r = 0.057, p = 0.875) or suppression ratio (r =
0.101; p = 0.780).
DISCUSSION
In this study, we examined the dynamics of visual responses in PD
across different foreground and surround stimulus contrasts. Our
results revealed three main characteristics of the visual response
in PD patients and provide a new perspective on the visual deﬁcits
reported in this disease. First, in PD there was a greater visual
response than in controls for ﬂickering stimuli presented in a nosurround conﬁguration: the visual response in patients peaked at
a signiﬁcantly higher level, and rapidly decayed over time. Second,
patients exhibited a marked suppression of the visual response in
the presence of surrounding stimuli. The inﬂuence of stimulus
context upon the ssVEP amplitude was robustly expressed on the
signiﬁcant decrease of ssVEP amplitude embedded in a surrounding stimulus of 100%, the maximum contrast. Third, the EEG
spectrum in PD showed a signiﬁcantly higher level of background
activity, or noise. These three ﬁndings challenge the notion that
reduced visual contrast sensitivity and visual deﬁcits observed in
PD mainly stem from retinal dysfunction.
The higher spectral power in patients over the theta, alpha and
beta bands (Fig. 1) derived from occipital electrodes are in line
with previous reports of increased spectral background over
centroparietal regions in alpha and beta bands, mostly during
dopaminergic therapy.31–34
The visual response in PD reached a higher initial amplitude and
more quickly decayed for visual stimuli of 75 and 100% contrast
and no surround. These results are in line with those of recent
animal work. For instance, in non-human primates, modulation of
dopaminergic forebrain circuits with D1 receptor antagonist
injected in a prefrontal cortical area enhanced the visual response
magnitude and orientation selectivity.35 Moreover, a PD model in
drosophila exhibited similar sensory enhancement, reﬂected in
response gain of the contrast response function.36 While the
Published in partnership with the Parkinson’s Foundation
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present ﬁndings are in agreement with such an enhancement of
visual responses in PD, previous human studies in PD found in
some cases, decreased VEP amplitudes or, in most cases, no
amplitude changes at all.8,37,38 Differences in stimulus characteristics may explain such discrepancy: stimuli were usually
presented in the center of the screen, covering a screen area
from at least 4–18 degrees of visual angle or full screen, at two
reversals per second.8,13–16 Owing to retinotopic organization,
evoked responses vary dramatically with stimulus location and
size and for large foveal stimuli electric ﬁelds generated in V1 tend
to self-cancel owing to cortical folding.28,39 As we have found an
exaggerated degree of suppression in PD, one could speculate
that with much larger stimuli, the greater mutual suppression
within the stimulus cancels out any increase in bottom-up
stimulus drive. A more likely explanation, however, may lie in
the differences in spatial frequencies used—we avoid those
previously found to illuminate retinally-mediated differences. In
general, our stimulation paradigm offers a view on unique aspects
of visual responses; whereas in previous work transient VEP
responses were evoked by sequentially presented stimuli in
200–500 ms epochs, our steady-state paradigm enables tracing
response dynamics continuously over a longer stimulation interval
(2.4 s), revealing a characteristic temporal proﬁle of rise and decay.
Although both groups showed a decrease of ssVEP amplitude
under the presence of surrounding stimuli, this surroundsuppression effect was proportionally stronger in patients. Visual
surround suppression is known to be generated by a variety of
lateral, feedforward, and feedback connectivity across many
hierarchical levels from retina ganglion and geniculate cells to
striate and extrastriate areas.29,30 Indeed, in PD, degeneration of
amacrine dopaminergic neurons might cause weakening of precortical center-surround interactions in the retina. However, we
found a signiﬁcantly greater surround-suppression effect in the
cortical responses of PD patients as well as steeper temporal
adaptation. Thus, we speculate that compensatory mechanisms
arising at the cortical level may account for the lack of centersurround interactions at the retinal level, and feedback from
extrastriate areas to V1 may have a major role in such
compensatory mechanisms,29,30,40 as is also suggested by recent
imaging studies.41
In our previous work, we found a relationship between the
degree of electrophysiological surround suppression and perception.27 In particular, the reduction of the point of subjective
equality of a stimulus when embedded in a high contrast
surround, as demonstrated earlier,42 correlates with the decrease
on the ssVEP amplitude measured using our paradigm. This
suggests that in patients with PD, perception of a stimulus may be
excessively decreased under the presence of a surround, a
prediction that will require future testing. The exaggerated spatial
and temporal gain control indices, coupled with the elevated level
of noise in which visual responses are embedded, may plausibly
contribute to the reduced visual contrast sensitivity often
observed in PD patients. However, the spatial frequency of our
stimuli was outside of the range previously found to exhibit
deﬁcits in PD,18,43 and whereas contrast sensitivity effects are
measured for low-contrast stimuli close to visual detection
threshold, our effects were observed for much higher contrasts.
Altogether, these ﬁndings highlight the need for systematic
examination of a broader range of visual stimulus features and
phenomena to attain a full understanding of visual system
abnormalities in PD.
Electrophysiological indices of visual surround suppression may
offer valuable insight into aspects of motor impairment in PD. For
instance, the results of our study can explain why patients with PD
and freezing of gait experience fewer freezing episodes while
walking when visual cues are present on the ﬂoor.44,45 Indeed,
salient stimuli help alleviate the freezing of gait episodes: one can
thus speculate that the corridor resembles the “foreground” or
Published in partnership with the Parkinson’s Foundation

central stimulus, embedded in “surrounding” objects, such as the
doorway and walls. In PD, the pronounced surround-suppression
effect is hypothetically present in a natural environment, with
strong contextual interactions that “suppress” responses to central
stimuli. Since only salient visual cues like the lines provide a
beneﬁt to freezing, such cues may have the potential to overcome
existing suppression of context upon a central stimulus. Of course,
for now this remains a speculation to be tested; our study had an
insufﬁcient number (n = 3) of patients with freezing of gait to
verify whether contextual effects were stronger in this subset of
patients.
This study has a few limitations. First, perceptual effects and
retinal functional or structural changes46 were not assessed
because of time constraints. Second, the relatively small sample
of patients warrants larger studies to conﬁrm and extend the
present ﬁndings. Third, our patients were on chronic dopaminergic therapy and were tested during regular medications schedule.
Although we did not ﬁnd any signiﬁcant relation between ssVEP
amplitude or suppression ratio with either PD duration or
levodopa equivalent dose, we cannot exclude that acute and
chronic dopaminergic treatment as well as disease duration could
play important roles in our results. Indeed, acute dopaminergic
treatment can improve PERG and PVEP in PD, but mostly at
intermediate spatial frequencies,14 a range that is outside the
spatial and temporal frequencies we used (1 cpd and 25 Hz). To
discern the role of the disease itself from the acute or chronic
dopaminergic treatment, future studies should verify whether
ssVEP amplitude or suppression ratio are present in just
diagnosed, drug-naive patients.
METHODS
Subjects
EEG data were collected on the surround-suppression paradigm as part of
a larger multi-test study of 28 patients with PD (seven women) and 30
healthy control subjects (20 women), which adopted inclusive recruitment
criteria that only required subjects to be right-handed and to show no
signs of dementia. As described below, all subjects also received a
complete neuropsychological assessment. Subjects were examined by a
movement disorder neurologist using the standardized rating scales for
cognitive and motor dysfunction: the Uniﬁed Parkinson Disease Rating
Scale (UPDRS) and the modiﬁed Hoehn and Yahr scale. All subjects had
normal or corrected-to-normal vision. All EEG recordings were conducted
with patients in ON during their usual dopaminergic medication schedule,
usually within one hour from their last medication.
The protocol was approved by the Institutional Review Board of The City
College of New York and NYU Langone School of Medicine. All participants
signed an informed consent form before the test.
In the present study, our ﬁnal analysis was conducted on subjects
without cognitive impairment and with sufﬁcient trials for unbiased
analysis of visual response magnitudes. Speciﬁcally, 10 controls and 10
patients were excluded because their MoCA scores were lower than 2647
and/or a diagnosis of depression; other four controls and seven patients
were excluded because the number of artifact-free trials was insufﬁcient to
measure response amplitudes unconfounded by differences in background spectral EEG levels (see analysis details below). We then selected
11 control subjects from the remaining sixteen to match the two groups
for age (see Tables 2 and 3), with the selection made randomly wherever
multiple options for inclusion existed.

Table 2. Description of subject groups and clinical assessment scores
in the ﬁnal subject pool
Patients

Controls

t, p

Age (years)

65.4 ± 4.5

66.7 ± 4.7

t20 = −0.69, p = 0.498

MoCA

27.6 ± 1.4

27.8 ± 1.7

t20 = −0.27, p = 0.786

All values are given as mean ± standard deviation. An independent sample
t test was performed

npj Parkinson’s Disease (2019) 13
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Table 3.

Patient characteristics

Patient Gender Age

Disease duration
(years)

Hoehn & Yahr Motor ﬂuctuations Dystonia Freezing of gait LED

Medication

1

M

60

8

2

Yes

Yes

Yes

100

Rasagiline

2

M

60

7

2.5

No

No

No

860

Sinemet Rasagiline Ropinirole

3

M

63

3

2.5

Yes

No

Yes

400

Levodopa

4

M

64

14

2.5

No

Yes

No

1130 Sinemet Ropinirole
Amantadine

5

M

64

8

2

Yes

Yes

No

400

6

F

64

7

2.5

No

No

No

850

Levodopa Amantadine

7

M

65

3

2.5

Yes

No

No

800

Sinemet Selegiline

8
9

F
M

66
66

4
4

2
2.5

No
Yes

No
Yes

No
No

100
850

Rasagiline
Sinemet

10

M

73

3

2.5

No

No

No

400

Sinemet Rasagiline

11

F

74

9

3

No

Yes

Yes

500

Sinemet Rasagiline

Sinemet Rasagiline

The AD8 Dementia Screening Interview, the four mini physical
performance test (MiniPPT) items and the Hospital Anxiety And Depression
Scale (HADS) revealed no signs of clinical depression or anxiety in the ﬁnal
pool of subjects, without signiﬁcant differences between the two groups
(AD8: PD = 1.55 ± 1.63, Ctrl = 1 ± 1.61; t20 = 0.79, p = 0.44; HADS Anxiety
Scale: PD = 4.27 ± 2.41, Ctrl = 3 ± 2.32; t20 = 1.26; p = 0.22; HADS Depression Scale: PD = 3.64 ± 2.01, Ctrl = 2.36 ± 2.06; t20 = 1.46; p = 0.16; MiniPPT:
PD = 13 ± 1.67, Ctrl = 14.1 ± 1.3; t20 = −1.7; p = 0.103).

EEG recordings

Experimental setup

Data analysis

Recordings were performed in a dark, sound-proof, radio-frequency
interference-shielded room. Stimuli were presented dichoptically on a
gamma-corrected CRT monitor (Dell M782) with a refresh rate of 100 Hz
and 800 × 600 resolution, at a viewing distance of 57 cm. Stimulus
presentation was programmed in MATLAB (The MathWorks Inc., Natick,
MA), using the Psychophysics Toolbox extension.48
Surround-suppression effects were tested using steady-state visual
responses to ﬂickering foreground stimuli embedded in static surrounds,
where stimuli in the upper ﬁeld were ﬂickered out-of-phase relative to
those in the lower ﬁeld. This method exploits anatomical and signalsummation principles to produce robust ssVEPs.28 The central “foreground”
stimulus was composed of four vertically oriented circular gratings, located
at an eccentricity of ﬁve degrees of visual angle, at polar angles of 20°
above (two upper disks) and 45° below (two lower disks) the horizontal
meridian. Disks ﬂickered on-and-off at 25 Hz, embedded within a nonﬂickering full-screen static “surround” (SS) also with vertical orientation,
parallel to the FG. In this conﬁguration, the “foreground” ﬂickering stimulus
is embedded into a “surrounding” pattern in order to induce maximum
visual surround-suppression effects using peripheral ﬂickering foreground
stimuli.27 In all cases, foreground and surround patterns were sinusoidally
modulated luminance gratings with a spatial frequency of one cycle per
degree. The average luminance of all gratings was equal to that of the
midgray, 0% contrast surround, which was 65 cd/m2. Foreground contrasts
could be 0% (midgray), 25%, 50%, 75%, or 100% (black and white stripes)
and static surround stimulus contrast could be 0%, 50%, or 100%, both
randomly assigned on each trial (see Fig. 3 insets, stimulus conﬁgurations
for FG 100% embedded in SS of 0% and 50% contrast).
For each of the contrast conditions, surround stimuli were presented
spatially in-phase and opposite-phase relative to the foreground,
interleaved pseudorandomly, and we collapsed across spatial phase
conditions within each conﬁguration to reduce border effects (see
Vanegas, et al.27). The full paradigm included a total of 120 trials (15
contrast combinations, four repetitions each for surround stimuli in and
out of phase with foreground). Each trial started with the presentation of a
ﬁxation spot for 500 ms, after which the ﬂickering foreground and static
surround stimuli were simultaneously presented for 2400 ms. Subjects
were instructed to maintain their ﬁxation on the center of the screen
throughout each trial.

Analysis was carried out ofﬂine using in-house Matlab scripts in
conjunction with topographic mapping functions of EEGLAB, an open
source toolbox for EEG analysis.49 Individual epochs were extracted in the
interval [−600:2600]ms relative to the visual stimulus onset at 0 ms. Blinks
were detected using an in-house blink detection script based on the
frontal electrodes with a threshold of 60 μV. Trial epochs were rejected if
they contained a blink or an artifact > 300 μV within the 2240-ms window
beginning 160 ms after stimulus onset, avoiding most of the early
component of the transient visual-evoked response. We baselinecorrected each trial epoch by subtracting the mean value over the points
[−50:0]ms and re-referenced all channels to average mastoids by simple
subtraction. We used Fourier decomposition to examine frequency spectra
and compute contrast response functions from ssVEP amplitude corresponding to increasing levels of “foreground” contrast with and without
“surrounding” patterns. The paradigm was designed to elicit visual sensory
responses at a high frequency (25 Hz), clear of the strongest endogenous
rhythms such as alpha (10 Hz). However, spectral amplitudes at any
frequency bin are inﬂuenced by differences in levels of background noise.
In PD, spectral power is known to be increased compared with
controls.31,33 The power increase is mainly evident over centroparietal
regions in the alpha and beta ranges in levodopa-treated patients.34 We
therefore began our analysis by examining the full EEG spectrum in the
entire cohort of subjects by computing the fast Fourier transform (FFT) for
the blank-screen (baseline) condition of FG = 0% and SS = 0% contrast
(Fig. 1 inset). We computed the FFT for a 2240-ms window beginning
160 ms after each stimulus onset and then averaged across trials, and
across electrodes over the central posterior midline region: Pz, POz, and
Oz, and neighboring electrodes, just as in Vanegas et al.27 This analysis
using the entire subject cohort conﬁrmed the background spectral
difference in PD subjects as has been previously reported in the literature
(Fig. 1).31,33
This difference in background EEG noise levels could potentially
confound comparisons of ssVEP amplitude between the two groups
because it causes all frequencies, including the precise frequency of the
ssVEP, to be elevated in PD. We thus carried out a noise-equalization
procedure to preclude this confound, whereby we averaged the ssVEP
measurements across fewer trials in the control subjects than in the PD
patients in such a way that background spectral levels were equalized. As
background brain rhythms are asynchronous to the ﬂickering onset, the
background spectrum (noise) is expected to decrease with trial number
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During each block, high-density electroencephalography data (Electrical
Geodesics Inc., Eugene, OR) were recorded from 256 electrodes at a sample
rate of 1000 Hz. We applied an online notch ﬁlter at 60 Hz. Impedances were
stable below 50 kΩ. We selected 183 channels on the scalp and downsampled to 500 Hz. Eye gaze was monitored continually using an
EyeLink1000 (SR-Research) eye tracker to ensure gaze was within one
degree of visual angle around the ﬁxation spot during stimulus presentation.
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Visual stimulation period: 2400ms
STFT: 560ms moving window

Raw EEG (μV)

Stimulus onset
FFT: 2240ms window

10
0
-10
0

500

1000

1500

2000

Time (ms)

Fig. 5 Methods of analysis of the visual response. Example raw EEG
traces in a PD patient (red) and a Ctrl subject (black), measured from
a cluster of parieto-occipital electrodes during a visual stimulation
trial, FG = 100% and SS = 0% contrast. Time frequency analyses, FFT
and STFT, were performed to extract the ssVEP amplitude at the
frequency of stimulation 25 Hz
when the FFT is computed on the average across trials. To determine the
trial numbers required for noise-matching, we computed the frequency
spectra for the blank-screen (0% foreground and 0% surround) condition
as a function of number of trials. For each number of trials, we randomly
selected this number 1000 times from the available trials for this blankscreen condition and then averaged the results. We found that spectral
background levels matched when the FFT was computed using the
maximum trial number in PD and approximately half the available number
of trials per condition in controls (Fig. 2). We consequently applied this
randomized trial selection, time-domain averaging and FFT procedure to
the estimation of ssVEP amplitude in all task conditions. As ssVEPs are
locked to the ﬂickering stimuli, signal averaging in the time domain
reduces the background noise without affecting the amplitude of the
average of the underlying oscillation. In this way, we equalized baseline
noise levels across groups, so that any difference on the ssVEP was
independent from the background spectral levels and not driven by
differences in spectral proﬁles. Contrast response functions were derived
by taking the number of trials for which equal levels of background
spectral noise are achieved in PD and Ctrl groups.
Subjects were excluded if the minimum amount of trials per condition (7–8
for patients with PD and 4 for controls) was not met for each of the 15 contrast
combinations after artifact rejection and blink detection. In the 11 PD and 11
control subjects included in the ﬁnal analysis, we veriﬁed that the levels of
background noise were still equalized using a t test (t20 = 0.689, p = 0.498).

Contrast response functions
In order to examine the inﬂuence of contextual surrounding patterns on
the ssVEP, we derived contrast response functions as described in Vanegas,
et al.27 A FFT was computed for a 2240-ms window beginning 160 ms after
stimulus onset to extract the single amplitude value at the frequency of
stimulation 25 Hz. To examine temporal dynamics, including the timecourse of adaptation, we computed a short-time Fourier transform (STFT)
on sliding windows of 560 ms with an overlap of 75% over the 2.4-s trial
length, starting from 280 ms prior to stimulus onset (Fig. 5).

inﬂuence of surround contrast in the denominator, and n is the exponent
that accounts for non-linearity of the function. As in spectral EEG
measurements the baseline level R0 reﬂects the noise ﬂoor (25-Hz
amplitude even in the absence of any stimulation), we use the max
function to reﬂect the fact that measurements cannot pass below this
noise ﬂoor. The time-dependent foreground drive Df(t) and suppressive
drive Ds(t) were modeled as decaying exponential functions beginning at
the veridical physical contrast of the stimulus and asymptotically tending
towards a fraction of that value, captured in the relations:

(2)
Df ðtÞ ¼ K 1;f C f þ C f 1  K 1;f et=τ

Ds ðtÞ ¼ K 1;s C s þ C s 1  K 1;s et=τ

(3)

where τ is the mutual time constant for adaptation of foreground and
surround drives and Cf and Cs are the foreground and surround contrasts,
respectively. K∞,f and K∞,s represent factors by which the foreground and
suppressive drive are asymptotically reduced relative to the initial value. The
ﬁt was carried out on the data over the interval 420–2240 ms so that FFT
windows stayed within the bounds of the stimulation period and using the
method of least-squares. The best ﬁt parameters of the model (see equations
1, 2, and 3) were as follows: PD subjects: Rm = 2.94, R0 = 0.43, n = 1.08, σ = 1,
β = 1.31, τ = 1371.15, K∞,f = 0.44, K∞,s = 0.77; Ctrl subjects: Rm = 1.92, R0 =
0.46, n = 0.9, σ = 1, β = 0.34, τ = 2549.21, K∞,f = 0.49, K∞,f = 1.

Statistical analyses
To ﬁrst of all test for differences in ssVEP amplitude as a function of group,
time, foreground contrast, and surround contrast, and/or interactions
between them, we carried out a mixed four-way ANOVA with two time
points taken early (420–560 ms) and late (1540–1680 ms) in the stimulation
epoch. To follow-up the interactions found in this test we assessed ssVEP
amplitude differences across groups for all individual conditions using
shufﬂe statistics with 1000 sampling iterations (random reassignment of
group). Shufﬂing was done per time point over the duration of the visual
stimulation (short-time Fourier transform), per stimulus condition. To test
for spectral differences in the blank-screen condition, we performed a
bootstrap analysis at each frequency bin. In this method, statistical samples
were obtained by resampling from the shufﬂed original sample 1000 times.
Surround-suppression effects and clinical scores were also tested using
independent samples t tests in cases where measures met the
Kolmogorov–Smirnov test for normality. When samples were not normally
distributed (i.e., slope of the line, temporal response), we conducted a
nonparametric Wilcoxon rank-sum test for independent groups. Correlation
analyses (Pearson) were computed to test for relationships between two
clinical scores (i.e., duration of the disease and motor score in the UPDRS
scale, in patients) and two electrophysiological metrics: (1) ssVEP amplitude
in the stimulus condition of FG = 100% and SS = 0%, and (2) surroundsuppression effect or suppression ratio, calculated as the ratio between
ssVEP amplitude corresponding to FG = 100%, SS=100% and the ssVEP
amplitude for FG=100%, SS=0%. In order to test for signiﬁcant differences
between the model parameter values ﬁt to the grand average of each
group, we used shufﬂe statistics; speciﬁcally, we randomly reassigned group
membership 500 times and ﬁt the model to the two false “groups” each
time to form a null distribution of parameter value differences across
groups, and compared the true parameter value difference against this null
distribution. The level of signiﬁcance was set at 0.05 in all tests.

Model ﬁt
As in our original study using this paradigm in young healthy subjects,27
we ﬁtted the grand average time-resolved contrast response functions
with a model accounting for variations over time as well as foreground and
surround contrast. First, the basic amplitude increase as a function of
foreground contrast was captured by the standard Naka-Rushton
function.50 Second, the inﬂuence of the spatial surround was encapsulated
in an additive term in the denominator. Third, the temporal adaptation of
both the foreground and surround drives was described by decaying
exponentials with the same time constant across contrasts levels and
stimuli (foreground and surround) but asymptotes that were permitted to
differ. The complete model is described by the relation:


Rm Dnf
; R0
rðCs ; Cf ; tÞ ¼ max n
(1)
n
n
Df þ β Ds þ σ
where r is the ssVEP amplitude at time t, Rm is the maximal response, R0 is
the spectral baseline noise, σ is the contrast at which half of the maximum
response is achieved, β is the coefﬁcient of suppression, which scales the
Published in partnership with the Parkinson’s Foundation
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